Physician profile
Martin Schoenmaker
NPI 1699873828
$2,039.40
in general payments reported to CMS, 2019-2025
32 companies · $82.04 in 2025
The $82.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $409 · 2021: $364 · 2022: $235 · 2023: $421 · 2024: $245 · 2025: $82.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $664.89 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Aspira Women'S Health INC | $207.83 | 2019-2023 | Ova1 |
| Biogen, INC. | $138.55 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $117.40 | 2019-2023 | Injectafer |
| Pfizer INC. | $96.40 | 2019-2024 | |
| Exeltis, USA INC. | $64.72 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $64.56 | 2020-2024 | Gardasil 9, Gardasil, Capvaxive |
| Davol INC. | $63.33 | 2023 | Arista Ah Flexitip |
| Coopersurgical, INC. | $51.28 | 2022-2024 | Paragard T 380a |
| Covidien LP | $50.00 | 2020 | |
| Therapeuticsmd, INC. | $47.86 | 2019-2022 | |
| Lupin INC. | $45.23 | 2019 | |
| Ethicon US, LLC | $40.12 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $37.53 | 2019-2022 | |
| Gynesonics, INC. | $34.87 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $34.41 | 2020 | |
| Mylan Pharmaceuticals INC. | $32.42 | 2021-2022 | |
| Albireo Pharma, INC. | $21.09 | 2022 | |
| Myovant Sciences INC. | $20.25 | 2021 | |
| Channel Medsystems, INC. | $20.04 | 2022 | |
| Convatec INC. | $19.66 | 2021 | |
| Amgen INC. | $18.33 | 2024 | Evenity, Prolia |
| Minerva Surgical, INC | $17.59 | 2021 | |
| Medtronic, INC. | $17.53 | 2024 | Truclear |
| Organon LLC | $16.56 | 2023 | Nexplanon |
| Novo Nordisk INC | $16.07 | 2024 | Wegovy |
| Astellas Pharma US INC | $15.74 | 2022 | |
| Agile Therapeutics, INC. | $14.58 | 2021 | |
| Intuitive Surgical, INC. | $13.43 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.91 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.16 | 2019 | |
| Alydia Health | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Schoenmaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.